Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men - Contacts and Locations

Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men

This study is ongoing, but not recruiting participants.
Information provided by Centers for Disease Control and Prevention

Please refer to this study by its ClinicalTrials.gov identifier: NCT00131677

Locations


United States, California
	San Francisco Department of Public Health
	San Francisco, California, United States, 94102

United States, Georgia
	AIDS Research Consortium of Atlanta
	Atlanta, Georgia, United States, 30308

United States, Massachusetts
	Fenway Community Health
	Boston,, Massachusetts, United States, 02115

Sponsors and Collaborators

Centers for Disease Control and Prevention

San Francisco Department of Public Health

AIDS Research Consortium of Atlanta

Investigators


Principal Investigator:	Kata L Chillag, PhD	Centers for Disease Control and Prevention

Principal Investigator:	Lisa A Grohskopf, MD, MPH	Centers for Disease Control and Prevention

Principal Investigator:	Susan Buchbinder, MD	San Francisco Dept. of Public Health

Principal Investigator:	Melanie Thompson, MD	AIDS Research Consortium of Atlanta

Principal Investigator:	Kenneth H. Mayer, MD	Fenway Community Health